Zuroflex HL

Zuroflex HL

One Shot to Regain Mobility
Move Freely, Live Fully.
Zuroflex-HL is a single-injection, cross linked Sodium Hyaluronate treatment to replace diseased synovial fluid and restore visco-elasticity in joints caused by osteoarthritis (OA).

Formulated using bacterial fermentation using a proprietary strain. Cross Linked Sodium Hyaluronate used in Zuroflex-HL is imported from HTL Biotechnology, France having high purity and biocompatibility.

Composition
Each ml contains:
Dosage Form
Dosage / Administration

Zuroflex HL is intended for a single injection regimen every six months. It can relieve pain and improve mobility for up to 6 months or more in patients with mild to moderate knee OA.

Storage
Store in a cool & dry place (2°C – 30°C). Protect from direct sunlight.
Warning
Product information provided is based on domestic versions. Information may vary according to country-specific policies and circumstances.

Learn More

HA Treatment For Knee OA
About HTL Biotechnology
About HTL Cross linked HA
Product Description:
Zuroflex HL is a sterile, apyrogenic, viscoelastic solution of cross-linked sodium hyaluronate (90 mg in 3 ml), designed specifically for intra-articular injection to restore the physiological and rheological properties of synovial fluid in patients suffering from knee osteoarthritis (OA).
Why Choose Zuroflex HL?
Zuroflex HL offers a premium-grade solution for long-lasting viscosupplementation. Its cross-linked structure enhances durability and therapeutic efficacy, making it a reliable choice for orthopedic professionals aiming for improved patient outcomes. 
Precautions:
  • Not for use in infected or severely inflamed joints
  • Contraindicated in patients with hypersensitivity to hyaluronate preparations
  • Should be used with caution in patients with bleeding disorders or active skin disease at the injection site
Benefits of Zuroflex HL:
  • Long-lasting pain relief (6 months or more in many patients)
  • Improved joint function and quality of life
  • Minimally invasive, outpatient procedure
  • Reduced need for oral analgesics or anti-inflammatory medications
Key Features:
  • High Molecular Weight Cross-linked HA: Ensures prolonged residence time and enhanced cushioning effect within the joint.
  • Single Injection Therapy: Convenient 3 ml pre-filled syringe offers effective symptomatic relief with one injection.
  • Biocompatible & Well-Tolerated: Derived via biofermentation, free of animal proteins, minimizing immunogenic reactions.
  • Lubrication & Shock Absorption: Improves joint mobility and reduces pain by enhancing the viscoelasticity of synovial fluid.